Immix Biopharma (IMMX) Leases (2024 - 2026)
Quarterly results put Leases at $927728.0 for Q1 2026, down 4.2% from a year ago — trailing twelve months through Mar 2026 was $927728.0 (down 4.2% YoY), and the annual figure for FY2025 was $966917.0, down 2.28%.
Immix Biopharma has reported Leases over the past 3 years, most recently at $927728.0 for Q1 2026.
- Leases reached $927728.0 in Q1 2026 per IMMX's latest filing, down from $966917.0 in the prior quarter.
- Across five years, Leases topped out at $1.1 million in Q1 2024 and bottomed at $927728.0 in Q1 2026.
- Median Leases over the past 3 years was $989471.0 (2024), compared with a mean of $988560.2.
- Peak annual rise in Leases hit 0.47% in 2025, while the deepest fall reached 8.11% in 2025.
- Over 3 years, Leases stood at $989471.0 in 2024, then dropped by 2.28% to $966917.0 in 2025, then decreased by 4.05% to $927728.0 in 2026.
- Business Quant data shows Leases for IMMX at $927728.0 in Q1 2026, $966917.0 in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 927,728.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 927,728.00 |
| Dec 31, 2025 | 966,917.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 947,103.00 |
| Mar 31, 2025 | 968,444.00 |
| Dec 31, 2024 | 989,471.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.05 Mn |